Patterns of chemotherapy use and outcomes in advanced non|small ...

Patterns of chemotherapy use and outcomes in advanced non-small ...

This observational study demonstrates that age is associated with treatment patterns in an older population with advanced NSCLC in England.

Patterns of chemotherapy use and outcomes in advanced non-small ...

Patterns of chemotherapy use and outcomes in advanced non-small-cell lung cancer in relation to age in England: A retrospective analysis of ...

Patterns of chemotherapy use and outcomes in advanced non-small ...

Patterns of chemotherapy use and outcomes in advanced non-small-cell lung cancer in relation to age in England: A retrospective analysis of the ...

patterns of chemotherapy administration for advanced non-small cell ...

Introduction: Chemotherapy prolongs survival without substantially impairing quality of life for medically fit patients with advanced non-small cell lung cancer ...

Patterns of Chemotherapy Administration for Advanced Non-small ...

Chemotherapy prolongs survival without substantially impairing quality of life for medically fit patients with advanced non-small cell lung cancer (NSCLC), ...

Patterns of chemotherapy use and outcomes in advanced non-small ...

Patterns of chemotherapy use and outcomes in advanced non-small cell lung cancer by age in England: A retrospective analysis of the population- ...

Patterns of chemotherapy use and outcomes in advanced non-small ...

We used the Systemic Anti-Cancer Treatment (SACT) dataset to describe changes in treatment plan and estimated 30 and 90-day mortality rates and median, 6-, and ...

Treatment patterns for advanced non-small cell lung cancer in the US

Platinum-doublet (PD) chemotherapy and unspecified chemotherapy regimens were the most commonly used first-line treatments (up to 71% and 96%, ...

Treatment Patterns and Clinical Outcomes Among Metastatic Non ...

1L treatment was chemotherapy in 9969 (93%) patients, and targeted therapy in 685 (6%). Median OS (mOS) for all patients in 1L was 12.3 months (95% confidence ...

Real-World Treatment Patterns and Clinical Outcomes After ...

The most common treatment regimens upon progression after anti–PD-(L)1/platinum-doublet chemotherapy were nonplatinum chemotherapy (50.5%), ...

Treatment patterns and clinical outcomes in patients with advanced ...

On the basis of multivariable Cox regression results, compared with patients who received 1L chemotherapy, lower risks of 1L discontinuation ...

Patterns and predictors of first-line chemotherapy use among adults ...

Relatively low rates of chemotherapy receipt have been observed in older patients diagnosed with advanced non-small cell lung cancer (NSCLC) in ...

An analysis of the Systemic Anti-Cancer Treatment (SACT) dataset

Objective: We described the patterns of chemotherapy use and outcomes in patients diagnosed with stage III or IV non-small cell lung cancer ...

Real-world treatment patterns and outcomes in US patients (pts ...

Real-world treatment patterns and outcomes in US patients (pts) with advanced non-small cell lung cancer (NSCLC) after platinum-based ...

A retrospective analysis of - Journal of Geriatric Oncology

Patterns of chemotherapy use and outcomes in advanced non-small cell lung cancer by age in England: A retrospective analysis of the.

Chemotherapy use and outcomes in patients with stage III or IV ...

Background: We described patterns of chemotherapy use and outcomes in patients with advanced small-cell lung cancer (SCLC) in relation to age using the ...

P2.31-06 Real-World Treatment Patterns and Outcomes in Patients ...

Limited treatment options exist for patients with advanced non-small cell lung cancer (aNSCLC) progressing on platinum-based chemotherapy (chemo) and ...

Treatment Patterns and Clinical Outcomes Among Patients with ...

For patients with metastatic non-small cell lung cancer, timely molecular testing is essential to determine the appropriate course of ...

Real-World Treatment Patterns, Overall Survival, and Occurrence ...

We identified 4033 patients with advanced NSCLC who received second-line therapy (47% of those who received first-line platinum-based ...

Real-world treatment patterns and outcomes of patients with ...

Data to guide treatment selection in metastatic nonsquamous (mNSq) non-small cell lung cancer (NSCLC) after progression on current ...